Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Short photoperiods improve cashmere growth and quality in goats by changing hormone levels and gene expression.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Hormone therapy might help improve women's appearance as they age.

A woman developed male characteristics after using unregulated hormone therapy.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Thyroid hormone receptor β1 is found in human hair follicles and helps them survive.

Lower SHBG levels may increase the risk of PCOS.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Stress hormones and autoimmune reactions can cause hair loss.

SHBG may be a useful early indicator and treatment target for PCOS.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Parathyroid hormone-related protein helps control hair growth phases in mice.

Thyroid hormone affects skin health, with too little causing rough, pale skin and too much leading to smooth, thin skin, and may also impact wound healing and skin conditions.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.